Memphis Pharmaceutical’s profits increase 9% YoY in H1 FY2025/26

Updated 2/1/2026 2:09:00 PM
Memphis Pharmaceutical’s profits increase 9% YoY in H1 FY2025/26

Arab Finance: Memphis Pharmaceutical and Chemical Industries achieved net profits after tax valued at EGP 281.778 million in the first half (H1) of fiscal year (FY) 2025/2026, according to the financial results.

The generated profits were higher by 5% year-on-year (YoY) than EGP 268.080 million.

Net sales increased by 21% YoY to EGP 955.522 million in H1 FY 2025/2026 from EGP 787.915 million.

In the first quarter (Q1) of FY 2025/2026, the net profits grew by 9% to EGP 152.965 million from EGP 140.856 million in Q1 FY2024/25.

Related News